Skip to main
WBA
WBA logo

Walgreens (WBA) Stock Forecast & Price Target

Walgreens (WBA) Analyst Ratings

Based on 25 analyst ratings
Hold
Strong Buy 8%
Buy 12%
Hold 60%
Sell 16%
Strong Sell 4%

Bulls say

Walgreens Boots Alliance is positioned favorably due to its extensive network of over 8,000 locations, ensuring that nearly three-quarters of Americans have convenient access to its services, primarily through prescription drug sales, which contribute approximately two-thirds of its revenue. The company's ongoing investments in expanding healthcare services, such as Health Corner and Village Medical, support its strategic shift toward an omnichannel model that enhances its role as a comprehensive healthcare provider. Furthermore, management's commitment to improving cash flow generation and reducing debt underscores a focus on financial stability and operational efficiency, creating a foundation for potential long-term growth.

Bears say

Walgreens Boots Alliance faces significant downside risks due to increased pricing pressure and a deteriorating retail environment, which could adversely affect its revenue generation. Additionally, the company's recent suspension of its quarterly cash dividend signals ongoing concerns about weak cash flow and a slower growth trajectory in the U.S. market. These factors contribute to a negative outlook on the stock's performance as the company navigates its long-term turnaround strategy.

Walgreens (WBA) has been analyzed by 25 analysts, with a consensus rating of Hold. 8% of analysts recommend a Strong Buy, 12% recommend Buy, 60% suggest Holding, 16% advise Selling, and 4% predict a Strong Sell.

This aggregate rating is based on analysts' research of Walgreens and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Walgreens (WBA) Forecast

Analysts have given Walgreens (WBA) a Hold based on their latest research and market trends.

According to 25 analysts, Walgreens (WBA) has a Hold consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $34.70, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $34.70, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Walgreens (WBA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.